Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Central delivery of Dicer-substrate siRNA: a direct application for pain research.

Doré-Savard L, Roussy G, Dansereau MA, Collingwood MA, Lennox KA, Rose SD, Beaudet N, Behlke MA, Sarret P.

Mol Ther. 2008 Jul;16(7):1331-9. doi: 10.1038/mt.2008.98. Epub 2008 Jun 3.

PMID:
18523447
[PubMed - indexed for MEDLINE]
2.

Potential applications of siRNA for pain therapy.

Ganju P, Hall J.

Expert Opin Biol Ther. 2004 Apr;4(4):531-42. Review.

PMID:
15102602
[PubMed - indexed for MEDLINE]
3.

Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.

Kitabgi P.

Curr Opin Drug Discov Devel. 2002 Sep;5(5):764-76. Review.

PMID:
12630297
[PubMed - indexed for MEDLINE]
4.

RNA interference in pain research.

Röhl T, Kurreck J.

J Neurochem. 2006 Oct;99(2):371-80. Review.

PMID:
17029593
[PubMed - indexed for MEDLINE]
5.

Delivering small interfering RNA for novel therapeutics.

Lu PY, Woodle MC.

Methods Mol Biol. 2008;437:93-107. doi: 10.1007/978-1-59745-210-6_3. Review.

PMID:
18369963
[PubMed - indexed for MEDLINE]
6.

Inhalable siRNA: potential as a therapeutic agent in the lungs.

Durcan N, Murphy C, Cryan SA.

Mol Pharm. 2008 Jul-Aug;5(4):559-66. doi: 10.1021/mp070048k. Epub 2008 May 21. Review.

PMID:
18491918
[PubMed - indexed for MEDLINE]
7.

siRNA and the lung: research tool or therapeutic drug?

de Fougerolles A, Novobrantseva T.

Curr Opin Pharmacol. 2008 Jun;8(3):280-5. doi: 10.1016/j.coph.2008.04.005. Epub 2008 May 14. Review.

PMID:
18485820
[PubMed - indexed for MEDLINE]
8.

Delivery vehicles for small interfering RNA in vivo.

de Fougerolles AR.

Hum Gene Ther. 2008 Feb;19(2):125-32. doi: 10.1089/hum.2008.928. Review.

PMID:
18257677
[PubMed - indexed for MEDLINE]
9.

Therapeutic potential of RNA interference for neurological disorders.

Sah DW.

Life Sci. 2006 Oct 4;79(19):1773-80. Epub 2006 Jun 15. Review.

PMID:
16815477
[PubMed - indexed for MEDLINE]
10.

siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.

Singh SK, Hajeri PB.

Drug Discov Today. 2009 Sep;14(17-18):859-65. doi: 10.1016/j.drudis.2009.06.002. Epub 2009 Jun 21. Review.

PMID:
19540929
[PubMed - indexed for MEDLINE]
11.

Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.

Takahashi Y, Nishikawa M, Takakura Y.

Adv Drug Deliv Rev. 2009 Jul 25;61(9):760-6. doi: 10.1016/j.addr.2009.04.006. Epub 2009 Apr 20. Review.

PMID:
19386274
[PubMed - indexed for MEDLINE]
12.

Maintaining the silence: reflections on long-term RNAi.

Raemdonck K, Vandenbroucke RE, Demeester J, Sanders NN, De Smedt SC.

Drug Discov Today. 2008 Nov;13(21-22):917-31. doi: 10.1016/j.drudis.2008.06.008. Epub 2008 Aug 7. Review.

PMID:
18620073
[PubMed - indexed for MEDLINE]
13.

siRNA delivery systems for cancer treatment.

Oh YK, Park TG.

Adv Drug Deliv Rev. 2009 Aug 10;61(10):850-62. doi: 10.1016/j.addr.2009.04.018. Epub 2009 May 5. Review.

PMID:
19422869
[PubMed - indexed for MEDLINE]
14.

Therapeutic opportunities of small interfering RNA.

Goyal BR, Patel MM, Soni MK, Bhadada SV.

Fundam Clin Pharmacol. 2009 Aug;23(4):367-86. doi: 10.1111/j.1472-8206.2009.00694.x. Review.

PMID:
19709318
[PubMed - indexed for MEDLINE]
15.

[Progress of studies on Dicer structure and function].

Peng JJ, Yan F, Chen HR, Chen JP.

Yi Chuan. 2008 Dec;30(12):1550-6. Review. Chinese.

PMID:
19073568
[PubMed - indexed for MEDLINE]
16.

Delivery of siRNA to the target cell cytoplasm: photochemical internalization facilitates endosomal escape and improves silencing efficiency, in vitro and in vivo.

Oliveira S, Høgset A, Storm G, Schiffelers RM.

Curr Pharm Des. 2008;14(34):3686-97. Review.

PMID:
19075744
[PubMed - indexed for MEDLINE]
17.

Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation.

Souazé F, Forgez P.

Peptides. 2006 Oct;27(10):2493-501. Epub 2006 Aug 4. Review.

PMID:
16889873
[PubMed - indexed for MEDLINE]
18.

The versatility of oligonucleotides as potential therapeutics.

Eckstein F.

Expert Opin Biol Ther. 2007 Jul;7(7):1021-34. Review.

PMID:
17665991
[PubMed - indexed for MEDLINE]
19.

RNAi therapeutics: a potential new class of pharmaceutical drugs.

Bumcrot D, Manoharan M, Koteliansky V, Sah DW.

Nat Chem Biol. 2006 Dec;2(12):711-9. Review.

PMID:
17108989
[PubMed - indexed for MEDLINE]
20.

Botulinum toxin for pain.

Casale R, Tugnoli V.

Drugs R D. 2008;9(1):11-27. Review.

PMID:
18095750
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk